Close menu




April 30th, 2020 | 09:45 CEST

Barrick Gold, Royal Dutch Shell, Newmont - which shares should you have now?

  • Investments
Photo credits: pixabay.com

Stock markets around the world are in recovery mode. Fear and panic over the spread of the corona virus is fading and greed is returning. COVID-19 has kept the world in suspense. After hesitant action by governments in Europe and North America, although curfews were imposed in the country of origin, China, as early as January 2020, drastic measures were not taken in most countries until March, which led to a social and economic standstill. Politicians were confronted with the uncertainty that many experts held different opinions and little faith could be placed in information from China. Many lives may have been at stake. A test for the people, politics and economy.

time to read: 2 minutes | Author: Mario Hose
ISIN: GB00B03MLX29 , CA0679011084 , US6516391066

Table of contents:


    Hard words from a politician

    The Lord Mayor of Tübingen, Boris Palmer (Die Grünen), personally drew a conclusion on the current measures to stem the spread of COVID-19 and summed it up in hard words: "We are saving people who might die soon anyway." The statement refers to the meanwhile gained knowledge that most victims of Corona are very old or have already had previous illnesses. However, for politicians, who decide on life and death with their decisions, the pressure was enormous.

    The information from the much-cited John Hopkins University could only serve as a trend due to the different regional survey methods. Sometimes the quality of this data fog can also lead to deceptive conclusions. Caution was the order of the day.

    All-clear in Germany

    The all-clear was recently sounded by the first reliable figures from North Rhine-Westphalia, with over 17.5 million inhabitants the most populous state in Germany. On the basis of the number of deaths in the month of March 2020, fortunately, no development could be found that suggests that COVID-19 increased the death rate. According to current figures, around 18,800 people died in the entire federal state in March 2020. In the same period last year, the number of deaths was around 19,100.

    The preliminary death figures for the first quarter of 2020 also give no indication of abnormalities. Thus, 53,900 people died in the first three months of this year compared to 55,600 in the same period last year. The figures for April 2020 will provide even more certainty for decisions on further steps. Finally, it remains to be seen whether the containment measures had an impact on this stable development.

    Gold protects against inflation

    Due to the extensive financial policy measures taken by central banks and governments worldwide, it is now expected that the money glut will lead to a rise in inflation. For this reason investments in the gold sector can be particularly lucrative in the coming years.

    In addition to the mining companies Barrick Gold and Newmont, the small companies focusing on the discovery of new gold deposits also offer enormous price potential. Desert Gold Ventures, Osino Resources, Scottie Resources and Triumph Gold offer investors the opportunity to participate in early stage value creation.

    Rely on the recovery of the oil market

    But in the current situation, energy companies such as BP, Royal Dutch Shell and Saturn Oil & Gas also offer opportunities to position for a global economic recovery. Demand for crude oil is expected to increase significantly again in the coming months.

    Due to the volatility of the oil price in recent weeks, it can be assumed that there will be fewer producers in the USA in the future. The financing banks will avoid the shale producers in the future, which will possibly lead to the fact that the USA will import more oil again, which plays into the cards of producers like Saturn Oil & Gas in Canada.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Mario Hose

    Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

    About the author



    Related comments:

    Commented by Stefan Feulner on October 4th, 2022 | 11:59 CEST

    RWE, Pathfinder Ventures, United Internet - Panic as an opportunity

    • Camping
    • Investments

    Last week, the crash prophets crawled out of their caves and outdid themselves with forecasts reaching the Corona lows at around 8,000 points in the leading German DAX index. Without a doubt, the general conditions for a sustained stock rally are moderate with the escalation of the Ukraine situation and concerns about further interest rate hikes. Nevertheless, there are attractive entry opportunities at the current level, which could pay off in cash in the long term.

    Read

    Commented by Juliane Zielonka on September 30th, 2022 | 10:59 CEST

    Biogen, XPhyto, BioNTech: Alzheimer's disease, depression, cancer - Pharma for life

    • Biotechnology
    • Pharma
    • Investments
    • Technology

    About 350 million people worldwide are affected by depression, a disorder of the brain. Each person also has a 16 to 20% chance of becoming depressed. Reason enough for the Canadian Company XPhyto Therapeutics to research a drug that is not addictive and can defeat the mental health-related medical condition. This week, Biogen, among others, achieved a breakthrough with an active substance against Alzheimer's disease. And if you follow the Bundesliga closely, you may be aware of the cases of testicular cancer among the players. Now BioNTech senses a new opportunity...

    Read

    Commented by Fabian Lorenz on September 29th, 2022 | 13:17 CEST

    Up to 200% share price potential: Kion, BioNTech, Aspermont in analyst check

    • Technology
    • Biotechnology
    • Investments

    The profit warning was a shock for Kion shareholders. Accordingly, the share price halved to EUR 20 in September alone. Now analysts are also slashing their estimates. The price targets for the forklift manufacturer are falling accordingly. Berenberg surprises with a high price target for the BioNTech share. At the same time, the analysts emphasize their hope for a continued generous dividend. Shareholders could thus be kept in good spirits until the next blockbuster. The roadshow of Aspermont in Germany has probably also created a good mood. At least the share price has jumped. The current consolidation could be an entry opportunity. Analysts see a price potential of over 200%.

    Read